Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site


Click on country-registry for comparison

Flag Country Registry Registration periodNo. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
China - Shangai1992-19951060104598.6151.40.30.50.50.198.761.9
India - Mumbai1992-199424321387.73012.37.40.40.04.592.212.5
Thailand - Chiang Mai1993-199713310478.22921.86.79.82.33.081.219.9
Thailand - Khon Kaen1993-19971189580.52319.512.74.20.81.782.218.1
Thailand - Lampang1990-2000169169100.000.00.00.00.00.0100.028.4
Thailand - Songkhla1990-199916810461.96438.18.915.56.07.769.626.7
Uganda - Kampala1993-1997493163.31836.732.74.10.00.063.36.3



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period